Reddit Posts
Halt Trade Strategies Discussion (example, VTGN)
Pre-Market, Low Float, Small Cap - Event-Driven Strategy
Cing didn’t got run on positive phase-3 but VTGN run on Successful Fasedienol Trial
VistaGen Therapeutics ($VTGN): A 3,471% surge unveiled - Discover the driving forces behind the explosive growth.
$SILO is working in the same Social Anxiety Disorder pace at $VTGN
Biotech on the Run: $VTGN. $SILO is on watch for similar biotech focus.
$VTGN Reacting to Good News Today, $SILO is a similar Biotech
$VTGN Reacting to Good News Today, $SILO is a similar Biotech
$VTGN is Soaring over 850% and $SILO is in the same Biotech Space.
VTGN (2.11->57.97->11.45 so far today)
VTGN is starting 2023 off with a BIG BANG!!
$SMMT, $VTGN--Pre-market Biotech Movers on News
Vistagen Therapeutics $VTGN proceed with the Phase 3 clinical trial of PH94B an acute treatment of anxiety in adults with SAD
All BBBY bag holders… dump it into $VTGN
$VTGN 600,000 CEO insider buys. 😁💚💪💹🤞🔥🔥🚀. $BBBY $GME $NVAX $PFE $GOVX app.quotemedia.com/data/downloadF…
$VTGN FDA Fast Track Designation Granted
$VTGN MONDAY TO THE MOON The company is evaluating potential study design modifications in the PALISADE Phase 3 program, including extended exposure periods,and is preparing to meet with FDA to discuss potential next steps for late-phase clinical development of PH94B.
$VTGN Phase 3 clinical trial Announced after market close of process consultation with FDA PALISADE-1 Imperfect PALISADE-1 Imperfect PALIS 9 Pre-Effect. Severe serious condition with PALISADE-1 or clinical PH 94B. In addition, the company evaluated the score of 200PALISADE
Does anyone have any information on VTGN?
To everyone who hated VTGN we are now green!
VTGN is on its way back! We will hit 0.25 at close. 👆
Last but in opportunity for VTGN!
VTGN to the moon tomorrow!
VTGN! Going to the moon tomorrow!
VTGN looks like a great play! Can’t wait for the morning!
VTGN as of 2022, phase 3 results this year for PH94B
VTGN made the list from the first article in this feed post
VTGN drug will replace benzodiazepines soon...
The penny stocks that are buys right now in the biopharmaceutical industry
VTGN gets $9 PT from Baird, calls stock "significantly undervalued."
VTGN gets $9 PT from Baird, calls stock "significantly undervalued."
Mentions
Good callout, are you still holding VTGN aswell?
Also just noting that VTGN is expected to release phase 3 results for an on going clinical trial called palisade 3 Sometime in Q4 of 2025.
If you boys and girls want a wild ride in biotech. Look at VTGN. I know some people with massive positions and if the results read out positive in November on their drug. Rocket 400% to 1200%
Regards want to play? VTGN releases results at the end of this month. Coin flip. If results are a repeat of their prior results this will rocket. If not you’ll lose 80%
Janus Henderson, 13.6% stake in $VTGN. BOOM \- [https://www.barchart.com/story/news/35067285/janus-henderson-just-took-a-13-6-stake-in-vistagen-should-you-buy-vtgn-stock-now](https://www.barchart.com/story/news/35067285/janus-henderson-just-took-a-13-6-stake-in-vistagen-should-you-buy-vtgn-stock-now)
Man, I love your energy here. VTGN has real potential, no doubt. The key is to treat plays like this as seeds, not lottery tickets. Even if the next data readout goes your way, the real wealth comes from repeating this process, researching deeply, sizing smartly, holding with patience. One big win is nice, but a lifetime of disciplined investing is how you change your future. Keep building, keep learning, and don’t lose sight of the bigger picture.
VTGN. 2 clinical trials both in phase 3 with results in q4 2025 and first half of 2026. made around 300% last time they announced positive results in 2023
Do less - buy NVDA, AMD, SOFI, VTGN, META, GOOG
KLAR? only 10 shares. Im still relatively new and this is my first time getting an IPO. But not really a penny stock. VTGN im at 500 at 3 but I want more so ill probably avg up
VTGN for me, been in this one for a long time and they have 2 ongoing clinical trials both in phase 3 with results expected q4 2025 and first half of 2026. possibility of a NDA if both have positive results.
Any thoughts on VTGN? Been in this one for a while, earnings report on the 7th AH and 2 potential upcoming catalysts. 1 in q4 this year and 1 in the first half of 2026.
Bought 600 shares of VTGN. Long term
I am VTGN at 2.06. I will probably buy more if it falls 2 or lower. I have seen it hit over 2.60 since I have held it. This is a long hold for me. I am going to hold it until 2026 when most of the clinical trials end. If it goes over 3 in 2025, I might sell it, but that's not the end goal.
Any views on VTGN calls
Hey, love this breakdown — thanks for bringing $VTGN back on the radar! That fasedienol angle is interesting, especially the part about non-sedative, fast-acting treatment for Social Anxiety Disorder. A couple quick questions though: * Did they share any new data on efficacy or just reiterate prior findings at the ADAA conference? * Do you know where they are in the FDA timeline — are we expecting Phase 3 readouts soon or still in mid-stage? * Any word on how they plan to commercialize fasedienol if approved — partner, go solo, or license it out? Also, out of curiosity, how do you think $VTGN stacks up right now against some other CNS/mood-focused names like: * **$MNMD (MindMed)** – Also targeting anxiety but with a psychedelic pipeline (MM-120 for GAD). Higher risk, but also drawing attention for novel mechanisms. * **$AXSM (Axsome Therapeutics)** – Their AXS-05 (approved for depression) gives them a revenue-generating foothold while they explore more indications. Stronger fundamentals but less upside room maybe? * **$PRAX (Praxis Precision Medicines)** – A bit broader in CNS but working on fast-acting neuropsychiatric therapies. Similar to $VTGN in trying to fill unmet needs but still in development phase for most.
Hey, love this breakdown — thanks for bringing $VTGN back on the radar! That fasedienol angle is interesting, especially the part about non-sedative, fast-acting treatment for Social Anxiety Disorder. A couple quick questions though: * Did they share any new data on efficacy or just reiterate prior findings at the ADAA conference? * Do you know where they are in the FDA timeline — are we expecting Phase 3 readouts soon or still in mid-stage? * Any word on how they plan to commercialize fasedienol if approved — partner, go solo, or license it out? Also, out of curiosity, how do you think $VTGN stacks up right now against some other CNS/mood-focused names like: * **$MNMD (MindMed)** – Also targeting anxiety but with a psychedelic pipeline (MM-120 for GAD). Higher risk, but also drawing attention for novel mechanisms. * **$AXSM (Axsome Therapeutics)** – Their AXS-05 (approved for depression) gives them a revenue-generating foothold while they explore more indications. Stronger fundamentals but less upside room maybe? * **$PRAX (Praxis Precision Medicines)** – A bit broader in CNS but working on fast-acting neuropsychiatric therapies. Similar to $VTGN in trying to fill unmet needs but still in development phase for most.
I thought $VTGN was drawing dead but the higher lows in the last couple weeks brought me back to it. Break through $2.30 would be huge
Agree, VTGN’s nasal spray pherine platform potentially can be first-in-class drugs for social anxiety disorder, MDD, and post-menopausal hot flashes. These conditions are demanding novel, more effective, safer drug options.
VTGN actually [developed the first drug to show positive Phase 3 data for acute treatment of Social Anxiety Disorder](https://beyondspx.com/article/vistagen-therapeutics-inc-nasdaq-vtgn-pioneering-neuroscience-with-promising-pherine-candidates). Their nose-to-brain pherine tech hits different - no systemic absorption needed like traditional meds. Got $119M cash to burn through trials too, not some penny stock pump n dump bs.
Hmm I’ll take a look. That one has definitely been talked about before I bet you could find something in this sub if you look up VTGN in the Reddit search bar
Check out VTGN. Do some DD for them as well?
Biotech plays are like playing Russian roulette with five bullets in the chamber - but at least these aren't another garbage AI stock pump. VTGN's nasal spray for social anxiety reminds me of the time I tried to cure my portfolio anxiety by snorting pre-workout powder at market open.
Biotech plays are like throwing darts at a board while blindfolded and drunk - except VTGN's [74.7M cash runway](https://finance.yahoo.com/quote/VTGN/balance-sheet?p=VTGN) means they're at least using premium darts while burning money on nose sprays that make you less awkward at parties.
Got into VTGN as well. Thanks folks. Looks legit and looks like a runner. I believe I am late to AUUD now so picking the next best winner
VTGN $2 puts 1/16/26 look chill q
VTGN, beaten down pharmaceutical company, if they can pass the upcoming FDA phases it’d expected to reach $14a share current $3
VTGN next year is going to pop off
Innovation and development; $VTGN was overvalued in the past for sure, but now you can easily make the argument their beyond undervalued.
VTGN. New social anxiety medication followed by many more. In the form of a nasal spray. First in it's class. Waiting for this one to blow up. Don't think there has been a new anxiety medication in years. It's seems to dodge the bad side effects of current anxiety medication directly through the nasal passage. Currently at the end of phase 3
Only down 15% with AKBA? I also have FGEN, PALI, and VTGN.
Check out VTGN, anxiety/depression nasal spray… bruh
VTGN. Making a new class of drug. Nasal spray for Social anxiety. Endless potential if it goes well. Currently phase 3 and fast tracked by the FDA
Vistagen $VTGN up pre market on positive Phase 2A trials
So much long term potential as well. Big things coming to VTGN
VTGN looks like it’s gearing up for a run
For a penny stock to get a decent run one of four things has to happen from my experience. 1- it’s rigged by mms and run up before an offering. This is usually the case in low floats or sometimes used to get to warrants that someone needs to cash in.. (CXAI is a good example).. 2- high short interest enough to get the attention of the rest of the market (TRKA GNS WHLR examples of this) 3- biotech phase 1,2 or 3 with amazing results in cancer or Alzheimer’s or another area with little to no effective treatments) ie TTOO VTGN SAVA etc) 4- expected large catalyst like Fda approvals Buyouts mergers buybacks big earnings ect NVOS TRKA ect and the best will fit into several of these categories.. high short interest low float big catalysts.. MCOM- stocks like this one that have had a ton of dilution end up leaving a bad taste for investors.. a stocks history and float size are important factors. Now could some discord come along and try and make some money off of it and have it run a couple cents.. sure but I can’t see myself any reason for the stock to go anywhere, but down and be reverse split. This is not financial advice but if I were you, I would be looking for a recent reverse split with a relatively low float under 5 million that has an upcoming catalyst and a decent amount of cash on hand so you don’t get stuck in an offering.. Research patience timing.. all extremely important. Small caps have been decimated over the last few years and things. Don’t look to be getting any better anytime soon. These are not long holds unless you wanna lose every cent you got. In and out done.
VTGN around .80c and sold around $13
If this stock even has a fraction of the squeeze that VTGN has I'm gonna make $10 million. I might get 2 Lambos! 1 for each middle finger!
Press Release: Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023 5:19 pm ET August 8, 2023 (Dow Jones) Print Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--August 08, 2023-- Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced it will host a conference call and webcast on Thursday, August 10, 2023, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and report results for its fiscal year 2024 first quarter ended June 30, 2023. Event: Vistagen Fiscal Year 2024 First Quarter Corporate Update Conference Call Date: Thursday, August 10, 2023 Time: 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) US Dial-in (Toll-free): 1-800-954-1051 TOLL/International Dial-in: 1-212-231-2924 Conference ID: 22027732 Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1627439&tp_key=9f0f4cb009
Kind of disappointed with paper hands here trying to make a quick buck out of TTOO. I’ve been making 5-10K from NKTR fluctuations every day, but not even touching TTOO despite $50-60L swings on profit every hour. It’s a bigger game. If and when the FDA approval comes through, I wouldn’t be surprised to see a VTGN repeat. As soon as TTOO goes down .2-3 cents, people start bringing up random stocks to confuse people. People who’ve existed TTOO during dips, I don’t think it’s still late to get back in. PS: It’s not a financial advise. Use your own judgement.
Probably. But with a moated technology, and I would think consistent sales of these test kits that go with them, I can sell half for profit above 1, go long with the other half. I’m out of my element with biotech, so I’m using TA to guide me here. Pissed off I missed out on being screwed by the market halt on $VTGN, wanted something to complain about this week 🤪🤣
24.00? Are you talking about VTGN?
They have very different products. CING is developing a drug for ADHD. AFAIK VTGN is developing a drug for Social Anxiety with Major Depressive Disorder.
Just yesterday, when VTGN made a 3000% move premarket, Robinhood randomly stopped allowing trades on it while it was still going up. Because Citadel was getting smashed on their short positions. But the regards in here won't get that. They pretending that a broker having a conflict of interest with their clients is some sort of conspiracy theory rather than standard practice 🤣🤣🤣 They belong here...
Yes, Thwitter is absolutely right. Medical stocks rely heavily on catalysts. Not only is TTOO waiting on FDA approval but it’s also the only device of its kind. Crazy enough to see a company (VTGN) that created a nasal drug for social anxiety shoot up 3000% so that is proof of potential.
$SILO Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders 📈 $VTGN ran 1000% yesterday on positive data…$SILO could be next up. Read news here: [https://ir.silopharma.com/single-news-releases/?webmasterId=104586&qmodStoryID=5435610220877266](https://ir.silopharma.com/single-news-releases/?webmasterId=104586&qmodStoryID=5435610220877266)
In recent years, psychedelic drugs have become more common in pipelines trying to develop treatment for crippling mental health conditions. I looked for companies developing treatments for MDD, SAD, PPD, and GAD. Some like $ATAI or $CMPS use shrooms, but ketamine has shown very promising effects in treating depression, especially treatment-resistant depression. I found $SEEL and $VTGN just searching for assets under proprietary formulation of ketamine. $SEEL uses a racemic ketamine while $VTGN is of the pherine family, so same receptor. They were both large gambles, so unfortunately I ended up only going with one
SEEL should have a nice pop in the future, but not anywhere near as much as VTGN. VTGN had a tiny float
Until it's not. Sometimes, you throw some lottos and this one is a solid one. Always risk. Anyway, congrats on VTGN.
Honestly, I'm hoping in the future $GSTC turns into a $VTGN. Still has a ways to go. But I was told about that, what a beauty.
TBH, I was a little worried about the earnings, but decided to hold because I believe it’s a longer term stock. The earnings have been much better than expected. So, the downside risk is quite limited at this point. It can only go up. $1 seems practical at this point! When the final FDA approval comes in, it could go VTGN route, and it does so, I am going take a month long vacation :) https://preview.redd.it/psy8z4lyfrgb1.jpeg?width=1170&format=pjpg&auto=webp&s=68dd9a4511fe6888fc6fbefd14ee92a5f344dbf0
Thanks, I was wondering why my response to the other VTGN thread was failing to post.
This is now the VTGN Megathread. All others will be deleted. Thanks!
$VTGN 16 February 2024 $5 put 🚨
$VTGN 19 January 2024 $6 put 🚨
$VTGN 1000% lmao wtf
VTGN what the fuck hahahaha look at that chart
I’m about to YOLO some into $VTGN 😂 can’t miss this madness
Someone somewhere bought a bag full of VTGN!
VTGN had a good news released thats why it went so crazy this morning
>VTGN holly what the hell is going on
I’ve held 50 shares of VTGN for years what the actual fuck is happening
Holy shit, VTGN just made a lot of people millionaires, 3,000 ducking percent, while people are still trying to shill boring “value” companies like Disney and PayPal.
Bought $VBLT $APSI $EPAZ $MULN $VTGN Sold $BNGO
VTGN boutta explode regardless of market sentiment
With a big push on volume VTGN could fill that gap from $.20 to $.80 for a 4x
$VTGN get in before the gap up!
Faraday Future $FFIE and Vistagen therapeutics $VTGN, both got huge potential
FFIE and VTGN just sayin
Im buying Faraday Future $FFIE and vistagen therapeutics $VTGN both got huge potentiel to skyrocket the next 2-3 weeks Maybe a month
VTGN is going to be a runner any time. Look at the trend.
MARK recent rs low float oversold like hell TCBP 500k float leukemia data update soon. Have been swinging but keeps getting squeezed 100%+ here n there. Not complaining RLX gamma squeeze setting up on those jan 2.50 calls delta .85 OI 29,440 2 calls Delta 1 oi 14k AWH swinging since .285 ovarian cancer test commercial launch soon hass been getting loaded last 2 weeks VTGN .1529 holding up .174 resistance needs to go. .245 stars gap fill to .994 SFT completed LOTZ merger recently. been consolidating since 170% run from .20/.24 until .314 test Good luck
VTGN is trending. Watch it. One dollar price target.
I was right about MULN. Next is VTGN which will be even better.
$ARDX The FDA approved their reapplication for Tenapanor for kidney patients. They also have many drugs already approved and in the pipeline but the one for kidney patients is big. It should run to $8.00 a share before the approval. $MMAT has a gazillion patents for cool technology. They’re having a conference starting today and they’re expected to announce contracts with big companies. Conference run’s January 5-8, 2023. $VTGN is inching forward every day. Next week will big with the JPMorgan conference. They make cancer drugs among others. Good Luck To All
This stock has always been an all-or-nothing proposition. If it goes up tomorrow by 20 cents or down by 5 cents it wouldn't alter my feelings one bit. After the July readout Baird and Jeffries Valued it at intrinsic value(11 cents), and guess what, it has barely budged from that price. But I still truly believe, after reading the science, stats, trends, webcasts, etc, that VTGN and at least ONE of its drug candidates has a good(70%) chance of making it to market.
Hey /u/MOJOIII - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: VTGN. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
Idk about the next cosm…but I’m sure enjoying that chance of gamma ramp in jan with BBBY, historical low prices, bond deal, standstill agreement ending, RC mystery, also about time for the usual 3-5 month run up. CEI announced split expected DEC 21 and could be a solid gainer whether it be a rip from ah today until day of or a dip on split then rip sort of like cosm but that was was a different type of run today because of the morning fuckery split shit that happened/didn’t happen don’t expect something like that again. VTGN had some huge buys right after market close I’ll be keeping my eyes on that for any news or momentum to trade with. Also liking coms for an entry could be a scalp or hold depending on price and volume for me. NFA! I just like the current movement/profit opportunities presented to me by personal analysis allowing me to find trading plans that suits my trading style 🙃